---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042947"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2026-09-16T21:05:23+00:00"
generated_at: "2026-09-16T21:06:10.100557+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ChronoScale extends $2M loan maturity to Nov 12, 2026; permits Ekso Bionics sale

## Summary
- Term loan of $2.0M outstanding extended to Nov 12, 2026 from Sept 12, 2026 via amendment with B. Riley Commercial Capital.
- Amendment allows sale of Guarantor Ekso Bionics, Inc. as Permitted Disposition, auto-releasing Lender's liens on sold assets/capital stock.
- Waiver dated Apr 23, 2026: Proposed Financing does not accelerate maturity but qualifies as Qualified Financing for conversion right.
- Loan Parties confirm $2M principal outstanding and no defenses; all other Note terms unchanged.

## SEC filing metadata
- accession: 0001493152-26-042947
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2026-09-16T21:05:23+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/0001493152-26-042947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042947
- JSON: https://secwatch.observer/filing/0001493152-26-042947.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.